TRACY TEAL: Open Payments
NPI 1851511992 · CHERAW, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 28 payments from 11 companies in 2025. Trend: 2023 $468 · 2024 $214 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $113 |
| Novo Nordisk Inc | 3 | $70 |
| Exact Sciences Corporation | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $34 |
| ACADIA Pharmaceuticals Inc | 2 | $33 |
| ABBVIE INC. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, Cologuard Collection Kit, Ozempic, CAPLYTA, GEMTESA, Dexcom G6 Transmitter, NUPLAZID, Auvelity.
Industry payments across SC — which companies pay providers there.
